213 related articles for article (PubMed ID: 20393189)
21. Rosiglitazone exerts neuroprotective effects via the suppression of neuronal autophagy and apoptosis in the cortex following traumatic brain injury.
Yao J; Zheng K; Zhang X
Mol Med Rep; 2015 Nov; 12(5):6591-7. PubMed ID: 26351751
[TBL] [Abstract][Full Text] [Related]
22. Recent advances in neuroprotection for treating traumatic brain injury.
Cernak I
Expert Opin Investig Drugs; 2006 Nov; 15(11):1371-81. PubMed ID: 17040197
[TBL] [Abstract][Full Text] [Related]
23. Traumatic brain injury: therapeutic challenges and new directions.
Vink R; Bullock MR
Neurotherapeutics; 2010 Jan; 7(1):1-2. PubMed ID: 20129491
[No Abstract] [Full Text] [Related]
24. Neuroprotection Trials in Traumatic Brain Injury.
Chakraborty S; Skolnick B; Narayan RK
Curr Neurol Neurosci Rep; 2016 Apr; 16(4):29. PubMed ID: 26883431
[TBL] [Abstract][Full Text] [Related]
25. The neuroprotective effects of progesterone on traumatic brain injury: current status and future prospects.
Wei J; Xiao GM
Acta Pharmacol Sin; 2013 Dec; 34(12):1485-90. PubMed ID: 24241345
[TBL] [Abstract][Full Text] [Related]
26. Modulation of traumatic brain injury using progesterone and the role of glial cells on its neuroprotective actions.
Feeser VR; Loria RM
J Neuroimmunol; 2011 Aug; 237(1-2):4-12. PubMed ID: 21777982
[TBL] [Abstract][Full Text] [Related]
27. Large animal models of stroke and traumatic brain injury as translational tools.
Sorby-Adams AJ; Vink R; Turner RJ
Am J Physiol Regul Integr Comp Physiol; 2018 Aug; 315(2):R165-R190. PubMed ID: 29537289
[TBL] [Abstract][Full Text] [Related]
28. Current state of neuroprotective therapy using antibiotics in human traumatic brain injury and animal models.
Ritter K; Somnuke P; Hu L; Griemert EV; Schäfer MKE
BMC Neurosci; 2024 Feb; 25(1):10. PubMed ID: 38424488
[TBL] [Abstract][Full Text] [Related]
29. Progesterone neuroprotection: The background of clinical trial failure.
Schumacher M; Denier C; Oudinet JP; Adams D; Guennoun R
J Steroid Biochem Mol Biol; 2016 Jun; 160():53-66. PubMed ID: 26598278
[TBL] [Abstract][Full Text] [Related]
30. Cyclosporine as Therapy for Traumatic Brain Injury.
Hansson MJ; Elmér E
Neurotherapeutics; 2023 Oct; 20(6):1482-1495. PubMed ID: 37561274
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of topiramate neuroprotective effect in severe TBI using microdialysis.
Alves OL; Doyle AJ; Clausen T; Gilman C; Bullock R
Ann N Y Acad Sci; 2003 May; 993():25-34; discussion 48-53. PubMed ID: 12853292
[TBL] [Abstract][Full Text] [Related]
32. A clinical/translational perspective: can a developmental hormone play a role in the treatment of traumatic brain injury?
Stein DG
Horm Behav; 2013 Feb; 63(2):291-300. PubMed ID: 22626570
[TBL] [Abstract][Full Text] [Related]
33. Medical treatment and neuroprotection in traumatic brain injury.
Clausen T; Bullock R
Curr Pharm Des; 2001 Oct; 7(15):1517-32. PubMed ID: 11562296
[TBL] [Abstract][Full Text] [Related]
34. Drug Repurposing in Neurological Disorders: Implications for Neurotherapy in Traumatic Brain Injury.
Shakkour Z; Habashy KJ; Berro M; Takkoush S; Abdelhady S; Koleilat N; Eid AH; Zibara K; Obeid M; Shear D; Mondello S; Wang KK; Kobeissy F
Neuroscientist; 2021 Dec; 27(6):620-649. PubMed ID: 33089741
[TBL] [Abstract][Full Text] [Related]
35. Recent advances in the development of multifactorial therapies for the treatment of traumatic brain injury.
Vink R; Van Den Heuvel C
Expert Opin Investig Drugs; 2004 Oct; 13(10):1263-74. PubMed ID: 15461556
[TBL] [Abstract][Full Text] [Related]
36. Erythropoietin as a neuroprotective agent in traumatic brain injury Review.
Mammis A; McIntosh TK; Maniker AH
Surg Neurol; 2009 May; 71(5):527-31; discussion 531. PubMed ID: 18789503
[TBL] [Abstract][Full Text] [Related]
37. Dextromethorphan provides neuroprotection via anti-inflammatory and anti-excitotoxicity effects in the cortex following traumatic brain injury.
Pu B; Xue Y; Wang Q; Hua C; Li X
Mol Med Rep; 2015 Sep; 12(3):3704-3710. PubMed ID: 26004757
[TBL] [Abstract][Full Text] [Related]
38. A review of laboratory and clinical data supporting the safety and efficacy of cyclosporin A in traumatic brain injury.
Lulic D; Burns J; Bae EC; van Loveren H; Borlongan CV
Neurosurgery; 2011 May; 68(5):1172-85; discussion 1185-6. PubMed ID: 21307793
[TBL] [Abstract][Full Text] [Related]
39. MLC901, a Traditional Chinese Medicine induces neuroprotective and neuroregenerative benefits after traumatic brain injury in rats.
Quintard H; Lorivel T; Gandin C; Lazdunski M; Heurteaux C
Neuroscience; 2014 Sep; 277():72-86. PubMed ID: 24993477
[TBL] [Abstract][Full Text] [Related]
40. Newer pharmacological approaches for antioxidant neuroprotection in traumatic brain injury.
Hall ED; Wang JA; Miller DM; Cebak JE; Hill RL
Neuropharmacology; 2019 Feb; 145(Pt B):247-258. PubMed ID: 30086292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
